BGI Genomics Co., Ltd.

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
40.65 ^CNY	+0.49%		-0.68%	-15.31%

20/05	US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says	MT
10/05	Bgi Genomics Co., Ltd. Approves Cash Dividend for 2023	CI

Bgi Genomics Co., Ltd. Announces Board Appointments

June 18, 2021 at 01:02 am IST

BGI Genomics Co., Ltd. approved appointment of Cao Ya and Du Lan as independent directors at its EGM held on June 17, 2021.

Latest news about BGI Genomics Co., Ltd.

US Legislation Banning Chinese Biotech Firms Will Suppress Legislation, BGI Says	20/05	MT
Bgi Genomics Co., Ltd. Approves Cash Dividend for 2023	11/05	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023	16/04	CI
BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38%	01/03	MT
BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
China stocks rise further on market rescue hopes; HK flat	07/02	RE
Wuxi AppTec Denies Ties to Military in Wake of US Draft Bill Targeting Chinese Biotech Firms	06/02	MT
US bill targeting Chinese biotech firms WuXi AppTec, BGI hits delay	03/02	RE
Correction: GemPharmatech Responds to US Legislation Concerns	30/01	MT
Correction: Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	30/01	MT
GemPharmatech Responds to US Legislation Concerns	29/01	MT
MGI Tech Responds to US BIOSECURE Act	29/01	MT
Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	29/01	MT
US House bill would curb genetic info sharing with China's Wuxi Apptec, BGI	26/01	RE
BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Chinese Shares Extend Losses as Bank Borrowing Plunges to 14-Year Low; BGI Falls 6% After M&A Announcement	14/23/14	MT
BGI Genomics to Acquire Health Management Firm; Shares Slump 6%	14/23/14	MT
BGI Genomics Co., Ltd. signed a share transfer agreement to acquire Shenzhen Huada Special Inspection Technology Co., Ltd. from Shenzhen BGI Hospital Management Holding Co., Ltd. for CNY 0.71 million.	12/23/12	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	11/23/11	CI
BGI Genomics Appoints COO	30/23/30	MT
Bgi Genomics Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 7 June 2023	01/23/01	CI
Bgi Genomics Co., Ltd. Approves Cash Dividend for 2022	11/23/11	CI
BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2022	01/23/01	CI

BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.

Sector

Biotechnology & Medical Research

Calendar

29/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
BGI GENOMICS CO., LTD.	-15.31%	213.03Cr
EXACT SCIENCES CORPORATION	-27.70%	987.05Cr
GUARDANT HEALTH, INC.	-16.78%	275.45Cr
VERACYTE, INC.	-21.41%	165.28Cr
MARAVAI LIFESCIENCES HOLDINGS, INC.	+68.70%	146.78Cr
CAREDX, INC	+29.75%	81Cr
SEEGENE, INC.	-5.02%	73Cr
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-29.39%	51Cr
CURIOX BIOSYSTEMS CO., LTD	+1.59%	30Cr
CYTOGEN, INC.	-24.93%	17Cr

Bio Diagnostics & Testing